Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 27, 2022

SELL
$42.05 - $47.77 $31,537 - $35,827
-750 Reduced 11.39%
5,837 $256,000
Q1 2022

May 04, 2022

BUY
$40.23 - $47.74 $32,183 - $38,192
800 Added 13.82%
6,587 $291,000
Q4 2021

Feb 14, 2022

BUY
$38.88 - $45.31 $16,679 - $19,437
429 Added 8.01%
5,787 $258,000
Q2 2021

Aug 13, 2021

BUY
$36.52 - $41.46 $195,674 - $222,142
5,358 New
5,358 $213,000
Q4 2020

Feb 04, 2021

SELL
$34.07 - $39.94 $182,547 - $213,998
-5,358 Closed
0 $0
Q3 2020

Oct 26, 2020

BUY
$38.11 - $42.99 $3,811 - $4,299
100 Added 1.9%
5,358 $202,000
Q2 2020

Aug 13, 2020

SELL
$37.87 - $43.58 $7,573 - $8,716
-200 Reduced 3.66%
5,258 $214,000
Q4 2019

Jan 31, 2020

BUY
$42.0 - $48.25 $8,400 - $9,650
200 Added 3.8%
5,458 $256,000
Q2 2019

Aug 12, 2019

SELL
$39.4 - $42.7 $4,925 - $5,337
-125 Reduced 2.32%
5,258 $210,000
Q2 2018

Aug 10, 2018

SELL
$39.61 - $42.76 $41,590 - $44,898
-1,050 Reduced 16.32%
5,383 $217,000
Q4 2017

Jan 30, 2018

SELL
$35.34 - $41.9 $17,670 - $20,950
-500 Reduced 7.21%
6,433 $228,000
Q3 2017

Nov 07, 2017

BUY
$39.44 - $41.55 $273,437 - $288,066
6,933
6,933 $281,000

Others Institutions Holding GSK

About GSK PLC


  • Ticker GSK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,033,689,984
  • Market Cap $69.3B
  • Description
  • GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...
More about GSK
Track This Portfolio

Track Lowe Brockenbrough & CO Inc Portfolio

Follow Lowe Brockenbrough & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lowe Brockenbrough & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Lowe Brockenbrough & CO Inc with notifications on news.